Major Customers (Details Narrative) |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2016
USD ($)
Breathlyzers
|
Dec. 31, 2015
USD ($)
Breathlyzers
|
|
| Concentration risk, percentage | 10.00% | |
| Customers Three [Member] | ||
| Concentration risk, percentage | 10.00% | |
| Concentration risk, number of customer | Breathlyzers | 3 | |
| Due from customers | $ | $ 490,725 | |
| Customers Three [Member] | Sales Revenue, Net [Member] | ||
| Concentration risk, percentage | 75.00% | |
| Customers Two [Member] | ||
| Concentration risk, percentage | 10.00% | |
| Concentration risk, number of customer | Breathlyzers | 2 | |
| Due from customers | $ | $ 435,261 | |
| Customers Two [Member] | Sales Revenue, Net [Member] | ||
| Concentration risk, percentage | 65.00% | |
| X | ||||||||||
- Definition Concentration risk number of customer. No definition available.
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|